The RWD & RWE Podcast

3 August 2022: Conversation with Ryan Moog, MBA, Clinical Trials Solutions at Datavant – We discussed about Building the Bridge between Trial data and Real-World Data: what is 'trial tokenization', how is it conducted, and why should we care? (i.e., how do we use these tokens in the future to enrich our studies?)

27 July 2022: Conversation with Jess Rabourn, CFA, CEO of WideTrial and Executive Producer of the Expanded Access Summit – We discussed the primary objective of any EAP to provide pre-approval treatment options in situations of unmet medical need ... and a critical secondary objective to generate ongoing RWD from a larger and more representative set of patients within the targeted indication.

20 July 2022: Conversation with Todd Somsel, VP, Commercial Lead, RWD Marketplace at Prognos Health – We discussed RWD Marketplaces and how the accessible RWD can be applied to clinical and outcomes research use cases.

13 July 2022: Conversation with David Stein, Independent eClinical Consultant at D. Bartley Consulting, and Ken Light, Independent Consultant, ClinScape – A conversation with SMEs from the eClinical Forum (https://eclinicalforum.org/about-us); meet Dave Stein, eClinical consultant (Parexel, ClinPhone, PhaseForward, Oracle) and Ken Light, eSolutions IT consultant (Omnicomm Systems, Oracle) for insights and in-the-trenches experience leveraging RWD in RCTs and RWE studies

29 June 2022: Conversation with Jennifer Webster, Senior Director, Precision Medicine RWE Lead at Pfizer – We discussed the paper published in Clinical Pharmacology & Therapeutics: "Use of Real- World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design" (https://pubmed.ncbi.nlm.nih.gov/34839524/), focused on insights and takeaways about these RWD/RWE use cases.

22 June 2022: Conversation with Kyle Flickinger, SVP– Real World Evidence Platform Solutions at REDCap Cloud – We discussed empowering health systems by embedding research infrastructure at the point-of-care to enableclinical research and evidence generation.

15 June 2022: Conversation with Erin Stewart PhD, Director of Clinical Operations and Head Scientist – We discussed the abstract presented earlier this year at The American Association for Cancer Research (AACR) annual conference. The abstract and presentation, "Developing a standardized framework for curating oncology datasets generated by manual abstraction and artificial intelligence" will be the focus, including insights and takeways about AI in oncology RWD-driven research.

08 June 2022: Conversation with Charlie Barr MD DrPH, Pivotal Strategic Consulting & Tom Haskell, RWExperts – We discussed critical considerations for finding the right external advisor-consultant in the RWD/RWE domain; and practical considerations based on the experiences of RWD/RWE consultants ("datapreneurs") with varying degrees of consulting tenure.

01 June 2022: Conversation with Wendy Charles PhD, Chief Scientific Officer at BurstIQ – We discussed organization & access of healthcare datasets and how they can be better positioned in the marketplace for life sciences R&D, supporting clinical & outcomes research

25 May 2022: Conversation with Alexa Berk King PhD, Medical Afairs Director, Digital Health & Data Platforms, & Rakesh Patel MD, Chief Medical Officer, Digital Health from Invitae – We discussed optimizing precision medicine with enhanced personalized decision support steming from an expanded view of RWD combined with genomics